Sage Therapeutics, Inc. (NASDAQ:SAGE) Receives $8.81 Average PT from Brokerages
Shares of Sage Therapeutics, Inc. (NASDAQ:SAGE – Get Free Report) have been given a consensus rating of “Hold” by the nineteen ratings firms that are currently covering the firm, Marketbeat reports. Two equities research analysts have rated the stock with a sell recommendation, fifteen have given a hold recommendation and two have assigned a buy […]
Shares of Sage Therapeutics, Inc. (NASDAQ:SAGE – Get Free Report) have been given a consensus rating of “Hold” by the nineteen ratings firms that are currently covering the firm, Marketbeat reports. Two equities research analysts have rated the stock with a sell recommendation, fifteen have given a hold recommendation and two have assigned a buy […]
